ErlotinibTablets it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR)â either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation âwhich has spread to other parts of the body.
Tags: Erlotinib Tabletsmanufacturer, Erlotinib Tablets exporter, Erlotinib Tablets supplier, Erlotinib Tablets, Erlotinib potassium, whogmp approved,Erlotinib potassium tablets manufacturer and supplier, Erlotinib Tablets distributor, Erlotinib Tablets drop shipper,Erlotinib Tablets 150 mg, Erlotinib Tablets 150 mg supplier, Erlotinib Tablets 150mg.
ISO/GMP/c-GMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approvedmanufacturing facility in Gujarat, India.
Registration: SaintroyLifescience is interested in registration of own brand or customer brands inministry of health of clientâs country and we also provide the productssamples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free salecertificate and other required documents.
Export Country : SaintroyLifescience export Erlotinib Tablets to USA, Canada, Germany, Europe,France, Ghana, Nigeria, Kenya, Senegal, Sudan, UAE, Kuwait, Dubai, Cameroon,Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand,Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala,Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia,Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan,Uzbekistan, Kazakhstan.